Curaleaf Holdings, Inc. (CURA) (CURLF), a leading international provider of consumer products in cannabis, reported its financial and operating results for the fourth quarter and year ended December 31, 2021.
Boris Jordan, Executive Chairman of Curaleaf, said that “2021 was another exceptional year for Curaleaf. We reached a significant milestone by generating over 90% revenue growth and exceeding $1.2 billion of total revenue for the first time. We continued to deliver gross and Adjusted EBITDA margin expansion and ended the year with one of the strongest balance sheets in the industry to support our ongoing growth strategies.”
2021 Fiscal Year
Revenue – $1.2B (93% increase)
Adjusted EBITDA – $298M (107% increase)
Revenue – $320M (39% increase)
Adjusted EBITDA – $80M (48% increase)